Celsion Corporation Announces ASCO 2015 GEN-1 Immunotherapy Phase 1b Results in Ovarian Cancer Presentation
May 13, 2015 at 17:01 PM EDT
Celsion Corporation (NASDAQ: CLSN), a fully integrated oncology drug development company, today announced that results from its Phase Ib ...